Cargando…
Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites
Drug treatment for toxoplasmosis is problematic, because current drugs cannot eradicate latent infection with Toxoplasma gondii and can cause bone marrow toxicity. Because latent infection remains after treatment, relapse of infection is a problem in both infections in immunocompromised patients and...
Autores principales: | Murata, Yuho, Sugi, Tatsuki, Weiss, Louis M., Kato, Kentaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469451/ https://www.ncbi.nlm.nih.gov/pubmed/28609444 http://dx.doi.org/10.1371/journal.pone.0178203 |
Ejemplares similares
-
Toxoplasma gondii Cyclic AMP-Dependent Protein Kinase Subunit 3 Is Involved in the Switch from Tachyzoite to Bradyzoite Development
por: Sugi, Tatsuki, et al.
Publicado: (2016) -
Nanosilver Colloid Inhibits Toxoplasma gondii Tachyzoites and Bradyzoites in Vitro
por: SHOJAEE, Saeedeh, et al.
Publicado: (2019) -
Toxoplasma gondii bradyzoites and tachyzoites isolation from vitreous of atypical necrotizing retinitis
por: Kharel(Sitaula), Ranju, et al.
Publicado: (2018) -
A rapid and simple single‐step method for the purification of Toxoplasma gondii tachyzoites and bradyzoites
por: El‐Ashram, Saeed, et al.
Publicado: (2020) -
MAG2, a Toxoplasma gondii Bradyzoite Stage-Specific Cyst Matrix Protein
por: Tu, Vincent, et al.
Publicado: (2020)